Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.53 USD | -2.32% | -4.17% | -79.66% |
01/04 | Signs of Softening Inflation Fuel Narrow Premarket Gains for US Equity Futures | MT |
01/04 | Top Premarket Decliners | MT |
Evolution of the average Target Price on Vivos Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Vivos Therapeutics, Inc.
Ascendiant Capital | |
Roth Capital Partners |
EPS Revisions
- Stock Market
- Equities
- VVOS Stock
- Consensus Vivos Therapeutics, Inc.